Robust and Long-lasting Efficacy of Durvalumab Consolidation in Stage III NSCLC after Induction Chemotherapy and definitive Chemoradiation: Focus on Treatment Choice and prognostic Factors

M. Guberina,C. Poettgen, N. Guberina, T. Gauler, M. Metzenmacher, M. Wiesweg, C. Richlitzki, T. Ploenes, M. Forsting, A. Wetter, K. Herrmann, H. Hautzel,K. Darwiche,D. Theegarten, C. Aigner,M. Schuler, W. E. E. Eberhardt, M. Stuschke

STRAHLENTHERAPIE UND ONKOLOGIE（2022）

引用 0|浏览5